Literature DB >> 11867808

Hepatic tumor detection: MR imaging and conventional US versus pulse-inversion harmonic US of NC100100 during its reticuloendothelial system-specific phase.

Flemming Forsberg1, Catherine W Piccoli, Ji-Bin Liu, Nandkumar M Rawool, Daniel A Merton, Donald G Mitchell, Barry B Goldberg.   

Abstract

PURPOSE: To compare conventional ultrasonography (US) and magnetic resonance (MR) imaging with contrast agent-enhanced US for detection of VX-2 liver tumors in rabbits.
MATERIALS AND METHODS: Conventional gray-scale liver US was performed in 65 rabbits, 38 of which had VX-2 hepatic tumor implants. Twenty minutes after contrast agent injection, gray-scale pulse-inversion harmonic US images of the liver-specific phase were obtained. Following sacrifice of the animals, T1- and T2-weighted MR imaging was performed at 4-mm intervals. Pathologic analysis was performed as the reference standard. The capability of each imaging modality to correctly depict tumor presence or absence and the number of tumors was compared.
RESULTS: Conventional US correctly depicted the presence or absence of tumors in 54 rabbits, for an accuracy of 83%, sensitivity of 71%, and specificity of 100%. With contrast-enhanced US, accuracy increased to 92% (60 correct cases); sensitivity, to 87%; and specificity, to 100%. MR imaging facilitated 56 correct diagnoses, for an accuracy of 86%, sensitivity of 82%, and specificity of 93%. There was a marginally significant difference between US with and US without contrast agent (P =.07) but not between MR imaging and contrast-enhanced US (P > or = .34). When the numbers of correctly detected tumors were compared, contrast-enhanced US performed significantly better than MR imaging (P =.02) and conventional US (P =.04).
CONCLUSION: There was no significant difference between contrast-enhanced US and MR imaging in the detection of hepatic tumors, whereas contrast-enhanced US had the highest accuracy (92%) of the three modalities studied.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11867808     DOI: 10.1148/radiol.2223001786

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  17 in total

Review 1.  [Vascular imaging with contrast-enhanced sonography for experimental use].

Authors:  M Krix; H-U Kauczor; S Delorme
Journal:  Radiologe       Date:  2005-06       Impact factor: 0.635

Review 2.  Recent applications of ultrasound: diagnosis and treatment of hepatocellular carcinoma.

Authors:  Hitoshi Maruyama; Masaaki Ebara
Journal:  Int J Clin Oncol       Date:  2006-08       Impact factor: 3.402

3.  Usefulness of Sonazoid contrast-enhanced ultrasonography for hepatocellular carcinoma: comparison with pathological diagnosis and superparamagnetic iron oxide magnetic resonance images.

Authors:  Keiko Korenaga; Masaaki Korenaga; Matakazu Furukawa; Takahiro Yamasaki; Isao Sakaida
Journal:  J Gastroenterol       Date:  2009-04-23       Impact factor: 7.527

4.  Three cases of angiomyolipoma: diagnostic imaging by contrast-enhanced ultrasonography.

Authors:  Yayoi Yamamoto; Yoshimasa Fujiwara; Seigo Yukisawa; Kiyoshi Matsueda; Masamichi Katori; Keiko Yamada; Atsushi Kohno
Journal:  J Med Ultrason (2001)       Date:  2009-12-29       Impact factor: 1.314

5.  Possible utility of contrast-enhanced ultrasonography for detecting spread of local anesthetic in nerve block.

Authors:  Hideaki Sasaki; Masanori Yamauchi; Takafumi Ninomiya; Haruyuki Tatsumi; Michiaki Yamakage
Journal:  J Anesth       Date:  2017-04-03       Impact factor: 2.078

6.  Differentiation between malignant and benign nodules in the liver: use of contrast C3-MODE technology.

Authors:  Bao-Ming Luo; Yan-Ling Wen; Hai-Yun Yang; Hui Zhi; Bing Ou; Jian-Hong Ma; Jing-Sheng Pan; Xiao-Ning Dai
Journal:  World J Gastroenterol       Date:  2005-04-28       Impact factor: 5.742

7.  Contrast enhanced ultrasound of hepatocellular carcinoma.

Authors:  Kazushi Numata; Wen Luo; Manabu Morimoto; Masaaki Kondo; Yosuke Kunishi; Tomohiko Sasaki; Akito Nozaki; Katsuaki Tanaka
Journal:  World J Radiol       Date:  2010-02-28

8.  Contrast-enhanced ultrasonographic findings of serum amyloid A-positive hepatocellular neoplasm: Does hepatocellular adenoma arise in cirrhotic liver?

Authors:  Mariko Kumagawa; Naoki Matsumoto; Yukinobu Watanabe; Midori Hirayama; Takao Miura; Hiroshi Nakagawara; Masahiro Ogawa; Shunichi Matsuoka; Mitsuhiko Moriyama; Tadatoshi Takayama; Masahiko Sugitani
Journal:  World J Hepatol       Date:  2016-09-18

9.  Detection of hepatic VX2 tumors in rabbits: comparison of conventional US and phase-inversion harmonic US during the liver-specific late phase of contrast enhancement.

Authors:  Jeong Min Lee; Ji Hyun Youk; Young Hwan Lee; Young Kon Kim; Chong Soo Kim; Chun Ai Li
Journal:  Korean J Radiol       Date:  2003 Apr-Jun       Impact factor: 3.500

10.  Sonazoid-enhanced sonography for guiding radiofrequency ablation for hepatocellular carcinoma: better tumor visualization by Kupffer-phase imaging and vascular-phase imaging after reinjection.

Authors:  Noriyuki Miyamoto; Kazuhide Hiramatsu; Kazuhiko Tsuchiya; Yukihiko Sato; Satoshi Terae; Hiroki Shirato
Journal:  Jpn J Radiol       Date:  2009-06-06       Impact factor: 2.374

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.